ATLANTA–(BUSINESS WIRE)–Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the first quarter ended March 31, 2023. During the first quarter, Mirion received a $150 million direct at-the-market…Read More
Mirion Announces First Quarter 2023 Financial Results and Reaffirms Full Year Guidance
